Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2023-12-15 00:00:00 ET · period of report 2023-12-15 · accession 0001209191-23-058891 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-15 | 2023-12-15 | ACAD | Kihara James | Principal Accounting Off | S - Sale | $28.30 | -2,000 | 11.0K | -15% | -$56.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-15 | S | D | 2,000 | $28.30 | 11,025 | D | — | — |